FDA Inspection
Lonza Biologics, Inc.Lonza Biologics, Inc. – FDA Inspection, Mar 7, 2024
Record Details
This FDA Inspection record concerns Lonza Biologics, Inc., with an inspection on March 7, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d26d327b-7e5e-44dc-a11f-5a0ed641f62d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1232144
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Lonza Biologics, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| April 16, 2026 | Not classified | New England District Office | Blood and Blood Products |
| February 6, 2026 | Not classified | New England District Office | |
| June 6, 2025 | Not classified | New England District Office | |
| July 12, 2024 | Not classified | New England District Office | |
| July 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Biologics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.